Drugs / AN2898
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01301508 | May → Nov 2011 | atopic eczema | Pfizer | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AN2898 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01301508 ↗ |
| Route | Topical | “Topically Applied AN2898 and AN2728” NCT01301508 ↗ |